Avanos Medical Inc Revenue Growth Rates (AVNS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Avanos Medical Inc   (NYSE: AVNS)
 

AVNS's Revenue Growth by Quarter and Year

Avanos Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AVNS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 182.20
FY 182.20

AVNSs Annual Revenue
Avanos Medical Inc 's Revenue in the fiscal year 2025 $ 0.00 millions
Avanos Medical Inc 's Revenue in the fiscal year 2024 $ 0.00 millions
Avanos Medical Inc 's Revenue in the fiscal year 2023 $ 672.70 millions
Avanos Medical Inc 's Revenue in the fiscal year 2022 $ 820.00 millions
Avanos Medical Inc 's Revenue in the fiscal year 2021 $ 744.60 millions




AVNS Revenue first quarter 2026 Y/Y Growth Comment
Avanos Medical Inc achieved in the first quarter 2026, above Company average Revenue improvement of 9.23% year on year, to $ 182.20 millions.

Looking into first quarter 2026 results within Medical Equipment & Supplies industry 89 other companies have achieved higher Revenue growth. While Avanos Medical Inc ' s Revenue increase of 9.23% ranks overall at the positon no. 1713 in the first quarter 2026.


AVNS Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 0.72 % 26.75 % -34.85 %
3rd Quarter September - 4.18 % -0.35 % -15.64 %
2nd Quarter June - 1.46 % 1.66 % -16.85 %
1st Quarter March 9.23 % 0.6 % -13.51 % -2.89 %
FY   - 1.73 % 2.11 % -

Financial Statements
Avanos Medical Inc 's first quarter 2026 Revenue $ 182.20 millions AVNS's Income Statement
Avanos Medical Inc 's first quarter 2025 Revenue $ 166.80 millions Quarterly AVNS's Income Statement


AVNS Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 2.2 % 5.71 % -16.89 %
3rd Quarter September - 1.67 % -0.99 % 1.01 %
2nd Quarter June - 4.38 % 3.5 % -11.95 %
1st Quarter March 0.72 % -7.13 % 17.01 % -11.86 %
FY (Year on Year)   - 1.73 % 2.11 % -


Back to AVNS Growth rate Comparisons >> Back to AVNS Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #90
Healthcare Sector #266
Overall #1713

Revenue Y/Y Growth Statistics
High Average Low
13.87 % -6.16 % -100 %
 
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #90
Healthcare Sector #266
Overall #1713
Revenue Y/Y Growth Statistics
High Average Low
13.87 % -6.16 % -100 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Avanos Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
17.01 % 0.56 % -16.89 %
(Mar 31 2024)  


AVNS's I. Quarter Q/Q Revenue Comment
Avanos Medical Inc achieved in the I. Quarter 2026 above company average sequential Revenue growth of 0.72%, to $ 182.20 millions, from $180.90 millions in the fourth quarter.

Within Medical Equipment & Supplies industry 68 other companies have achieved higher Revenue quarter on quarter growth. While Avanos Medical Inc 's Revenue growth quarter on quarter, overall rank is 1669.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #69
Healthcare Sector #223
Overall #1669
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #69
Healthcare Sector #223
Overall #1669
Revenue Q/Q Growth Statistics
High Average Low
17.01 % 0.56 % -16.89 %
(Mar 31 2024)  


AVNS's I. Quarter Q/Q Revenue Comment
Avanos Medical Inc achieved in the I. Quarter 2026 above company average sequential Revenue growth of 0.72%, to $ 182.20 millions, from $180.90 millions in the fourth quarter.

Within Medical Equipment & Supplies industry 68 other companies have achieved higher Revenue quarter on quarter growth. While Avanos Medical Inc 's Revenue growth quarter on quarter, overall rank is 1669.


Avanos Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 714.20 $ 698.80 $ 697.50 $ 690.40 $ 687.90
Y / Y Revenue Growth (TTM) 3.82 % 1.73 % 7.47 % 6.28 % 6.35 %
Year on Year Revenue Growth Overall Ranking # 1922 # 0 # 2719 # 2052 # 2323
Seqeuential Revenue Change (TTM) 2.2 % 0.19 % 1.03 % 0.36 % 0.15 %
Seq. Revenue Growth (TTM) Overall Ranking # 2616 # 0 # 2066 # 1476 # 1880


Cumulative Revenue growth Comment
Avanos Medical Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 3.82% year on year, to $ 714 millions if the fiscal year would have ended in Mar 31 2026.
Avanos Medical Inc 's trailing twelve months Revenue growth was higher than company's average 0.96% and higher than 1.73% growth in Dec 31 2025.
But from twelve months ended Dec 31 2025 rise was beneth at 2.2 % from $698.8 millions achieved in the period from Dec 31 2025 to Mar 31 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0.96%.
The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 2.2 % increase from $698.8 millions in the period from Dec 31 2025 to Mar 31 2025.

In the Healthcare sector 299 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1922.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 300
Overall # 1922

Revenue TTM Y/Y Growth Statistics
High Average Low
400.67 %
 0.96 %
-149.02 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 375
S&P 500 # 2616
Cumulative Revenue growth Comment
Avanos Medical Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 3.82% year on year, to $ 714 millions if the fiscal year would have ended in Mar 31 2026.
Avanos Medical Inc 's trailing twelve months Revenue growth was higher than company's average 0.96% and higher than 1.73% growth in Dec 31 2025.
But from twelve months ended Dec 31 2025 rise was beneth at 2.2 % from $698.8 millions achieved in the period from Dec 31 2025 to Mar 31 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0.96%.
The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 2.2 % increase from $698.8 millions in the period from Dec 31 2025 to Mar 31 2025.

In the Healthcare sector 299 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1922.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 300
Overall # 1922

Revenue TTM Y/Y Growth Statistics
High Average Low
400.67 %
0.96 %
-149.02 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 375
S&P 500 # 2616




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AVNS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Electromed Inc 15.85%$ 15.851 millions
Penumbra Inc15.62%$ 15.616 millions
Innovage Holding Corp 15.49%$ 15.495 millions
Mannkind Corporation15.08%$ 15.082 millions
Theravance Biopharma inc 15.02%$ 15.018 millions
Dexcom Inc 14.99%$ 14.990 millions
Enanta Pharmaceuticals Inc14.96%$ 14.960 millions
Elanco Animal Health Incorporated14.92%$ 14.920 millions
Biofrontera Inc 14.87%$ 14.870 millions
Biolife Solutions Inc 14.85%$ 14.849 millions
Lineage Cell Therapeutics Inc 14.85%$ 14.847 millions
Repligen Corp14.83%$ 14.827 millions
Biorestorative Therapies Inc 14.60%$ 14.596 millions
Pro dex Inc 14.56%$ 14.557 millions
Atricure Inc 14.42%$ 14.420 millions
Idexx Laboratories Inc14.26%$ 14.259 millions
Livanova Plc14.20%$ 14.197 millions
Ligand Pharmaceuticals Incorporated14.09%$ 14.093 millions
Exagen Inc 13.77%$ 13.767 millions
Concentra Group Holdings Parent Inc 13.74%$ 13.740 millions
Immunocore Holdings Plc13.63%$ 13.630 millions
Petvivo Holdings Inc 13.33%$ 13.326 millions
Alphatec Holdings Inc 13.30%$ 13.302 millions
Anika Therapeutics Inc 12.91%$ 12.912 millions
Qhslab Inc 12.90%$ 12.901 millions
Cvrx inc 12.74%$ 12.744 millions
Iradimed Corporation12.65%$ 12.651 millions
Dbv Technologies S a 12.50%$ 12.500 millions
Abbvie Inc 12.43%$ 12.433 millions
Novocure Limited12.30%$ 12.298 millions


About Avanos Medical Inc Revenue Growth Rates (AVNS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Avanos Medical Inc (CIK 1606498).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001606498-26-000063
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Avanos Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.